172@29@17@138!~!172@29@0@53!~!|news|tags|kiran-mazumdar-shaw.html|page-3|!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
kiran mazumdar shaw
Jump to
167 Results Found
  • Speciality offers better returns, says Biocon Chief Dec 22, 2016 12:02 PM IST

    Speciality offers better returns, says Biocon Chief

    Biocon is among the companies that gave a good performance in 2016 and the stock surged 80 percent this year. Speaking to CNBC-TV18, Kiran Mazumdar Shaw, CMD of the company, said the company has gained traction in many emerging markets with its biosimilars.

  • Syngene fire could cost co several crores; losses insured: MD Dec 13, 2016 10:06 AM IST

    Syngene fire could cost co several crores; losses insured: MD

    A massive fire broke out at Syngene facilty near Bengaluru last evening but in a relief no casualties were reported as the incident took place after office hours. But, the damage in terms of value will run in several crores, said company's MD, Kiran Mazumdar Shaw.

  • Demonetisation has impacted Indian sales, not exports: Biocon Dec 06, 2016 12:52 PM IST

    Demonetisation has impacted Indian sales, not exports: Biocon

    Speaking to CNBC-TV18, Kiran Mazumdar Shaw, CMD of Biocon said huge opportunities exist for Biocon in the US biosimilars market.

  • Demonetisation to help leapfrog to digital economy: Biocon CMD Nov 24, 2016 02:28 PM IST

    Demonetisation to help leapfrog to digital economy: Biocon CMD

    The CMD of Biocon Ltd, which was rated among the world's top ten employers in the biotechnology industry by an international magazine recently, said she is confident that the demonetised currency would be replaced by the new notes reasonably soon.

  • Half of US stunned, other half exhilarated with Trump win: Shaw Nov 09, 2016 09:49 PM IST

    Half of US stunned, other half exhilarated with Trump win: Shaw

    In an interview with CNCB-TV18, Kiran Mazumdar Shaw, CMD of Biocon said that people worldwide are losing confidence in entrenched political systems and many feel marginalized and neglected from the economic developments that happen.

  • India witnessing 'jobless' growth: Kiran Mazumdar-Shaw Nov 03, 2016 01:22 PM IST

    India witnessing 'jobless' growth: Kiran Mazumdar-Shaw

    The Chairperson and MD of Biocon Ltd said restrictive e-regulations that try to protect conventional bricks and mortar jobs are an example of this.

  • Future jobs to be driven by digital tech: Kiran Mazumdar-Shaw Oct 31, 2016 01:38 PM IST

    Future jobs to be driven by digital tech: Kiran Mazumdar-Shaw

    Automation and digital technologies will drive jobs of the future even as they cannibalise conventional employment while creating a large number of new opportunities, says biotech entrepreneur Kiran Mazumdar-Shaw.

  • Biocon ranked among world's top 10 employers in Biotech Oct 29, 2016 02:00 PM IST

    Biocon ranked among world's top 10 employers in Biotech

    The company has moved up to No 9 in 'Science 2016 Top Employer' ranking from No 13 last year, Biocon said in a release.

  • Malaysian facility to be commercialised in H2 FY17: Biocon Oct 21, 2016 05:38 PM IST

    Malaysian facility to be commercialised in H2 FY17: Biocon

    Biotechnology major Biocon on Friday said its manufacturing facility in Malaysia will be commercialised in the second half of the current financial year.

  • Biosimilars to lead growth; generics to be a small part: Biocon Oct 21, 2016 11:56 AM IST

    Biosimilars to lead growth; generics to be a small part: Biocon

    Biotechnology major Biocon reported 19.8 percent rise in revenue to Rs 796.2 crore year-on-year and margins grew to 25.2 percent from 21.2 percent in the second quarter of FY17. The company‘s standalones sale grew 17 percent in Q2.

  • Time to act tough; no negative impact on economy: India Inc Sep 29, 2016 05:22 PM IST

    Time to act tough; no negative impact on economy: India Inc

    "The Indian economy has a strong bandwidth to deal with any possible after effects of the current state of tensions with Pakistan," Assocham Secretary General D S Rawat said.

  • Public health a worry; privatisation a must: Kiran Mazumdar Shaw Sep 28, 2016 10:45 AM IST

    Public health a worry; privatisation a must: Kiran Mazumdar Shaw

    Speaking to CNBC-TV18 Kiran Mazumdar Shaw, CMD, Bicon, said that India still has a long way to go on the infrastructure front. “Public health is a major worry; it is under invested.” Mohandas Pai also spoke to the channel.

  • India Inc mood was negative under UPA: Biocon founder Kiran Shaw Sep 05, 2016 07:36 PM IST

    India Inc mood was negative under UPA: Biocon founder Kiran Shaw

    In his interview to Network 18, Narendra Modi had said that he did not reveal the full economic rot before his first Budget as he thought that it would depress business and investor sentiment further

  • Kiran Mazumdar appointed 'Knight of Legion of Honour' by France Sep 01, 2016 03:18 PM IST

    Kiran Mazumdar appointed 'Knight of Legion of Honour' by France

    Chevalier l'Ordre National de la Legion d'Honneur, created in 1802 by Napoleon Bonaparte, is the highest civilian award of the French Republic for outstanding contribution in diverse fields bestowed on citizens of the world.

  • Trastuzumab marketing approval may come in 12-18 months: Biocon Aug 26, 2016 09:13 AM IST

    Trastuzumab marketing approval may come in 12-18 months: Biocon

    The European Medicines Agency (EMA) has accepted to review Mylan and Biocon‘s application for a biosimilar called Trastuzumab, used for certain breast and gastric cancers.

  • India Inc hopes Urjit Patel will balance growth with inflation Aug 21, 2016 12:18 AM IST

    India Inc hopes Urjit Patel will balance growth with inflation

    YES Bank MD and CEO says the new Reserve Bank Governor should go beyond focusing on consumer price index as the anchor of monetary policy and must also take into account wholesale price index.

  • Biocon to launch insulin glargine in Malaysia in H2 FY17 Jul 22, 2016 03:58 PM IST

    Biocon to launch insulin glargine in Malaysia in H2 FY17

    The biosimilar product, which is developed and manufactured by Biocon, has already been launched by its partner Fujifilm Pharma Co in Japan earlier this month.

  • Biocon bets on biosimilars for global ascendancy Jul 01, 2016 06:02 PM IST

    Biocon bets on biosimilars for global ascendancy

    Biotechnology major Biocon is banking on four advanced programmes aimed at treating cancer, diabetes and psoriasis to emerge as a leading global player in the field of biosimilars, Biocon Chairperson Kiran Mazumdar-Shaw has said.

  • Brexit to force Indian firms to rework biz strategy: Industry Jun 24, 2016 06:36 PM IST

    Brexit to force Indian firms to rework biz strategy: Industry

    As Brexit roiled financial markets, top industry leaders today said India cannot be in a denial mode as the referendum has opened a "pandora's box of grave uncertainties" and Indian companies, especially in IT sector, will have to rework their strategies for the region

  • FDI in pharma via automatic route a welcome step: Biocon Jun 20, 2016 02:21 PM IST

    FDI in pharma via automatic route a welcome step: Biocon

    The government eased foreign direct investment in pharma sector and Kiran Mazumdar Shaw of Biocon says it is a step in the right direction.

  • SBI chief, ICICI Bank head among 4 Indians in Forbes' new list Jun 08, 2016 12:56 PM IST

    SBI chief, ICICI Bank head among 4 Indians in Forbes' new list

    The Forbes '100 Most Powerful Women' in the world list 2016, topped by German Chancellor Angela Merkel, includes PepsiCo Chief Indra Nooyi, Biocon Founder Kiran Mazumdar-Shaw and HT Media head Shobhana Bhartia.

  • Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the  American Society of Clinical Oncology (ASCO) Annual Meeting Jun 04, 2016 08:18 AM IST

    Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting

    Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of data from the HERITAGE study at ...

  • US, Europe filings to drive Biocon growth: Kiran Mazumdar-Shaw May 24, 2016 10:11 AM IST

    US, Europe filings to drive Biocon growth: Kiran Mazumdar-Shaw

    These market filings have a market opportunity of USD 40 billion. In particular, Japan offers a market potential of USD 150 million for its insulin product Glargine, says Biocon's Chairman and Managing Director.

  • Biosimilar insulin Glargine to make $100 m from FY18: Biocon Apr 27, 2016 11:59 AM IST

    Biosimilar insulin Glargine to make $100 m from FY18: Biocon

    Biocon R&D team is working on the second phase of the development of oral insulin, and Kiran Mazumdar-Shaw, Chairman & MD, Biocon, hopes that it becomes an approved product in the next 2-3 years.

  • Realisations from insulin biosimilar to start from FY17: Biocon Mar 28, 2016 04:04 PM IST

    Realisations from insulin biosimilar to start from FY17: Biocon

    Getting approval to sell the biosimilar drug Glargine in Japan will open doors for the company, feels Kiran Mazumdar Shaw, Chairperson and Managing Director of Biocon.

Sections